Covering Disruptive Technology Powering Business in The Digital Age

Home > Archives > News > Esker to Automate Juniper Biologics Accounts Payable Processes
Esker to Automate Juniper Biologics Accounts Payable Processes
April 20, 2022 News


Esker, a global cloud platform and leader in AI-driven process automation solutions for finance and customer service functions, has announced that Juniper Biologics, a science-led healthcare company focused on Researching, Developing and Commercialising novel therapies, has selected Esker to automate its accounts payable (AP) processes.

With Esker, Juniper Biologics intends to digitally transform its AP operations into a highly collaborative, efficient and visible process. Eliminating manual tasks and processing invoices on a single platform, Esker’s Accounts Payable solution will support Juniper Biologics in improving operational efficiency by giving employees and suppliers the visibility and information they need to speed up the AP process.

“We are continually investing in our business processes to scale alongside our growing needs and to allow our people to focus on more strategic activities that impact cash management and improve supplier relationships,” said Raman Singh, CEO at Juniper Biologics. “AI-powered intelligence and technology are vital for driving business insights and increasing innovation, and Esker is the perfect fit for Juniper Biologics as we continue our automation journey.”

“In a fast-changing and challenging business environment, accelerating the adoption of advanced technologies that improve the workplace and retain talent is highly critical,” said Albert Leong, Managing Director at Esker Asia. “By reducing mundane and repetitive manual tasks in core finance processes, businesses can provide a collaborative environment for all internal and external stakeholders, thereby promoting positive-sum growth. We are very happy to be partnering with Juniper Biologics in their digital transformation initiative.”